biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > Success Consciousness vs. Failure Consciousness:

<< Previous

Bullboard Posts

Next >>

Comment by Boomskidon Jan 02, 2023 11:06am

98 Views

Post# 35199542

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Success Consciousness vs. Failure Consciousness:

Yeah, that was interesting.

The acquired calls it a merger and the buyer calls it an acquisition.

Merger is the worst kind of spin. It is so insulting of shareholder intelligence.

I call it the picking up of billions of dollars off the sidewalk, dropped there by Bioasis who weren't even aware they'd dropped it on their way to a BoD meeting, held for the sole purpose of picking up their 50 grand payment for the meeting.

Acquisition, merger...

You say tomahto and I say tomayto.
Let's call the whole thing off...

boo boopee doop

JD

<< Previous

Bullboard Posts

Next >>

Canadian artificial intelligence ETFs